Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
-
New pill shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis phase 2 trial tested an oral drug called AZD4205 in 57 adults with relapsed or refractory peripheral T-cell lymphoma, a rare blood cancer. The study aimed to see if the drug can shrink tumors and how safe it is. Participants took a capsule once daily in 28-day cycles.
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Healthy men swallow radioactive drug to track its path
Knowledge-focused CompletedThis study gave 6 healthy men a single dose of a radioactive form of the experimental drug DZD8586. The goal was to see how the drug moves through the body, how it is broken down, and how it leaves the body in urine and stool. This information helps researchers understand the dru…
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC